H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care.

Maguire, Paul A; Reay, Rebecca E; Looi, Jeffrey C L

Maguire, Paul A; Reay, Rebecca E; Looi, Jeffrey C L.

Maguire PA; Academic Unit of Psychiatry and Addiction Medicine, The Australia National University Medical School, Canberra, ACT 2605, Australia; Consortium of Australian-Academic Psychiatrists for Independent Policy and Research Analysis (CAPIPRA), Canberra, ACT, Australia. Electronic address: paul.maguire@act.gov.au.
Reay RE; Academic Unit of Psychiatry and Addiction Medicine, The Australia National University Medical School, Canberra, ACT 2605, Australia.
Looi JCL; Academic Unit of Psychiatry and Addiction Medicine, The Australia National University Medical School, Canberra, ACT 2605, Australia; Consortium of Australian-Academic Psychiatrists for Independent Policy and Research Analysis (CAPIPRA), Canberra, ACT, Australia.

Schizophr Res ; 237: 101-102, 2021 11.

Article in English | MEDLINE | ID: covidwho-1377832

Subject(s)

COVID-19; Schizophrenia; Humans; Pandemics; SARS-CoV-2; Schizophrenia/epidemiology; Schizophrenia/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Schizophr Res Journal subject: Psychiatry Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google